Boston Scientific (BSX) Total Liabilities (2016 - 2025)
Boston Scientific (BSX) has disclosed Total Liabilities for 17 consecutive years, with $19.2 billion as the latest value for Q4 2025.
- Quarterly Total Liabilities rose 8.94% to $19.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.2 billion through Dec 2025, up 8.94% year-over-year, with the annual reading at $19.2 billion for FY2025, 8.94% up from the prior year.
- Total Liabilities hit $19.2 billion in Q4 2025 for Boston Scientific, up from $19.1 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $41.6 billion in Q2 2025 to a low of $11.2 billion in Q1 2021.
- Historically, Total Liabilities has averaged $26.7 billion across 5 years, with a median of $31.6 billion in 2021.
- Biggest five-year swings in Total Liabilities: soared 188.03% in 2022 and later crashed 53.02% in 2023.
- Year by year, Total Liabilities stood at $34.5 billion in 2021, then decreased by 3.66% to $33.2 billion in 2022, then tumbled by 53.02% to $15.6 billion in 2023, then rose by 12.94% to $17.6 billion in 2024, then increased by 8.94% to $19.2 billion in 2025.
- Business Quant data shows Total Liabilities for BSX at $19.2 billion in Q4 2025, $19.1 billion in Q3 2025, and $41.6 billion in Q2 2025.